If you do not know: Schering-Plough funded a study between its drug Vytorin-- a combo of Zocor and Zetia, vs. Zocor alone.The results were expected: the combo Vytorin reduced cholesterols and other parameters better than Zocor alone.The other results were not expected: the combo was no better than single Zocor in preventing artery thickening.SP tried to delay the results of the trial: cue righteous